17 Stocks That May Have A Monster Final 4 Months of 2018
It’s September, and the chase for performance is on as investors flock into some of the hottest stocks around. We give you 17 that may have a monster final four months.
Read moreDaily Market Analysis By Michael Kramer
It’s September, and the chase for performance is on as investors flock into some of the hottest stocks around. We give you 17 that may have a monster final four months.
Read moreBiotech Stocks May Have Finally Been Unleashed Michael Kramer and the Clients of Mott Capital Own CELG [widget id=”text-19″] Stocks continued to move higher, led by the Biotech’s, which were…
Read more[widget id=”text-23″] Biotech and Tech Stocks Are Approaching Make Or Break Moments The stock market picked right up from where it left off last week, with the S&P 500 continuing…
Read more[widget id=”wordads_sidebar_widget-41″] Why Biotech Stocks Will Continue To Reach Record Heights [widget id=”text-16″] Biotech stocks continue to rip higher, with the S&P Biotech ETF ($XBI) reaching a new record high,…
Read more[widget id=”text-15″] [widget id=”wordads_sidebar_widget-41″] Stock Market Sells Off As Biotech Gets Rocked, Again! Just more of the same isn’t? Gap up at the open, then a slow drag lower the…
Read more